Back to 
UBS Group AG
UBS Group AG
SLXN1 quarters
Position history for UBS Group AG's holdings in SILEXION THERAPEUTICS CORP
UBS Group AG holds 1,411 shares of SLXN (SILEXION THERAPEUTICS CORP), worth $3,598 as of 2026-Q2. This is a new position.
Current Value
$3,598
Current Shares
1,411
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of SLXN: HRT FINANCIAL LP, ROYAL BANK OF CANADA